Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Non-cash Items (2023 - 2024)

Coeptis Therapeutics Holdings has reported Non-cash Items over the past 2 years, most recently at $1.1 million for Q1 2024.

  • Quarterly results put Non-cash Items at $1.1 million for Q1 2024, down 14.65% from a year ago — trailing twelve months through Mar 2024 was $1.1 million (down 14.65% YoY), and the annual figure for FY2023 was $1.2 million, changed.
  • Non-cash Items for Q1 2024 was $1.1 million at Coeptis Therapeutics Holdings, down from $1.2 million in the prior quarter.
  • Over the last five years, Non-cash Items for COEPW hit a ceiling of $1.3 million in Q1 2023 and a floor of $1.1 million in Q3 2023.